Charities
(continued from last week)
Dr B. Levine and Professors S. Perry and J. Coote, Pounds 110,684 from British Heart Foundation (analysis of the molecular mechanisms of phosphorylation-modulated calcium regulation of cardiac function); Professor J. Coote and Dr R. Empson, Pounds 70,823 from Beit Memorial Fellowship for Medical Research (fellowship); Dr M. Hodgkin and Professor A. Rickinson, Pounds 76,937 from BMFMR (fellowship); Professor P. Gallimore, Pounds 58,577 from CRC (structural, genetic, biochemical and biological studies on adenovirus oncoproteins)
Professor W. Wakelam, Pounds 56,975 from Wellcome Trust (mechanism of phospholipase D regulation); Dr L. Seymour and Professor D. Kerr, Pounds 73,469 from CRC (core funding); Dr P. Cane, Pounds 63,843 from the Wellcome Trust (role of genetic variability in the epidemiology of respiratory syncytial virus); Dr J. Neuberger, Pounds 71,910 from British Liver Trust (investigation into the pathogenesis of primary biliary cirrhosis); Drs D. Adams and R. Jones, Pounds 107,787 from British Digestive Foundation (generation of tumour specific cytolytic T cells from human hepatocellular carcinoma); Dr R. Stockley, Pounds 105,617 from British Lung Foundation (regulation of human neutrophil elastase gene transcription); Dr M. Gammage, Pounds 82,012 from BHF (effects of alternative right ventricular site pacing on cardiac function in patients with dual-chamber pacemakers implanted for high degree atrioventricular block); Dr N. Craddock and Professor I. Brockington, Pounds 287,762 from Wellcome Trust (genetic linkage studies of biopolar disorder in nuclear families); Professor P. Gallimore, Pounds 30,692 from CRC (structural, genetic, biochemical and biological studies on adenovirus oncoproteins); Dr R. Stockley, Pounds 24,155 from West Midlands Chest Fund (modulation of neutrophil function); Dr C. Gordon, Pounds 34,641 from LUPUS UK (systemic lupus erythematosus); Drs D. Pilling and M. Salmon, Pounds 122,966 from ARC (homeostatic regulation of resting and activated T cell apoptosis response); Professor R. Mitchell, Pounds 237,175 from Royal Society (five-year fellowship); Professor J. Heath, Pounds 415,406 from Wellcome Trust (structure and function of fibroblast growth factor receptors); Dr O. Smart, Pounds 38,528 from Wellcome Trust (fellowship); Dr P. Anderson and Professor P. Edwards, Pounds 86,305 from Royal Society (fellowship); Dr M. Charles, Pounds 132,000 Anonymous (hot particle dosimetry); Dr A. Mackenzie, Pounds 117,360 from Royal Society (fellowship).
Research contracts
Mrs A. Peters, Pounds 62,562 from University Hospital Birmingham NHS Trust (EQA core computing system research and development); Professor F. Hobbs, Drs B. Delaney, R. Walt and M. Kendall Pounds 34,396 from NHS Exec. North Thames RHA (NHS national research and development primary and secondary care interface programme: a prospective controlled evaluation of a joint primary/secondary care protocol for open access; Dr A. Gillies, Pounds 36,611 from NHS Executive (national research and development programme: periconceptual folic acid supplementation); Professor F. Hobbs, Pounds 62,394 from Pfizer Ltd. (Indo-asians with hypertension study); Professor E. Maher, Drs F. MacDonald and D. Morton Pounds 60,000 from NHS Exec. (molecular genetic investigation of colorectal cancer susceptibility); Mr S. Bramhall, Pounds 50,000 from British Biotech Pharmaceuticals Ltd (pivotal multi centre randomised double blind placebo controlled study of Marimastat in patients with inoperable gastric cancer) and, with Dr D. Adams, Pounds 50,000 from British Biotech Pharmaceuticals Ltd. (double blind randomised placebo controlled multi-centre trial evaluating the efficacy and safety of two doses of Lexipafant in severe acute pancreatitis).
to be continued
For further information see Netgazette http://thesis.www.co.uk